Cyteir Therapeutics
Developing the next generation of synthetic lethal therapies to treat cancer. Learn more
Launch date
Employees
Market cap
AUD167m
Enterprise valuation
(AUD32m) (Public information from Mar 2024)
Share price
$3.01 CYT
Lexington Kentucky (HQ)
Authorizing premium user...